Boston Therapeutics, Inc.

Boston Therapeutics, Inc. is a pharmaceutical company focused on the development, manufacture and commercialization of novel compounds based on complex carbohydrate chemistry to address unmet medical needs in the areas of diabetes and inflammatory diseases.

Latest News

InformationAboutDiabetes.com:
Boston Therapeutics On The Verge of a Blood Sugar Breakthrough - An Interview With CEO Dr. Platt

Boston Therapeutics Article on UnionLeader.com:
CEO says sugar kills, and he's working on a solution

Genetic Engineering & Biotechnology News:
Addressing Unmet Medical Needs with Complex Carbohydrate Chemistry

Featured Products

PAZ320

Blood Glucose Management

Prevention of Diabetes and its complications

• Prevention and Treatment of Type II Diabetes
• Novel, non-systemic appraoch to blood sugar management
• Chewable dose
• See more information »

Ipoxyn^TM

Universal Oxygen Carrier

Prevention of Necrosis & Ischemic conditions

• Injectable continuous IV
• Safe molecule
• No blood-type matching required
• No supplemental oxygen required
• No supply shortages
• See more information »